MiMedx Group Inc (MDXG)
9.22
+0.16
(+1.77%)
USD |
NASDAQ |
Nov 21, 16:00
9.215
0.00 (0.00%)
After-Hours: 20:00
MiMedx Group Gross Profit Margin (Quarterly): 81.77% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 81.77% |
| June 30, 2024 | 82.97% |
| March 31, 2024 | 84.67% |
| December 31, 2023 | 84.06% |
| September 30, 2023 | 81.90% |
| June 30, 2023 | 83.28% |
| March 31, 2023 | 82.67% |
| December 31, 2022 | 80.68% |
| September 30, 2022 | 81.99% |
| June 30, 2022 | 82.32% |
| March 31, 2022 | 83.13% |
| December 31, 2021 | 86.03% |
| September 30, 2021 | 83.94% |
| June 30, 2021 | 81.28% |
| March 31, 2021 | 83.92% |
| December 31, 2020 | 84.22% |
| September 30, 2020 | 84.00% |
| June 30, 2020 | 84.72% |
| March 31, 2020 | 83.76% |
| December 31, 2019 | 83.37% |
| September 30, 2019 | 85.14% |
| June 30, 2019 | 85.54% |
| March 31, 2019 | 88.85% |
| December 31, 2018 | 88.76% |
| September 30, 2018 | 91.54% |
| Date | Value |
|---|---|
| June 30, 2018 | 90.28% |
| March 31, 2018 | 88.88% |
| December 31, 2017 | 90.58% |
| September 30, 2017 | 88.65% |
| June 30, 2017 | 88.70% |
| March 31, 2017 | 87.96% |
| December 31, 2016 | 83.68% |
| September 30, 2016 | 87.59% |
| June 30, 2016 | 87.11% |
| March 31, 2016 | 85.11% |
| December 31, 2015 | 90.38% |
| September 30, 2015 | 89.84% |
| June 30, 2015 | 88.86% |
| March 31, 2015 | 87.37% |
| December 31, 2014 | 90.90% |
| September 30, 2014 | 90.01% |
| June 30, 2014 | 89.29% |
| March 31, 2014 | 84.78% |
| December 31, 2013 | 82.71% |
| September 30, 2013 | 86.89% |
| June 30, 2013 | 83.73% |
| March 31, 2013 | 83.52% |
| December 31, 2012 | 83.93% |
| September 30, 2012 | 82.08% |
| June 30, 2012 | 77.17% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
80.68%
Minimum
Dec 2022
86.03%
Maximum
Dec 2021
83.23%
Average
83.32%
Median
Gross Profit Margin (Quarterly) Benchmarks
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 77.14% |
| IGC Pharma Inc | 48.06% |
| NovaBay Pharmaceuticals Inc | 65.26% |
| Protalix BioTherapeutics Inc | 53.37% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 75.27% |
| Return on Assets | 43.45% |
| Return on Invested Capital | 60.77% |
| Profit Margin (Quarterly) | 9.63% |
| Operating Margin (Quarterly) | 13.63% |
| Return on Net Operating Assets | 72.27% |